Relpax (eletriptan) for migraines

March 2003

Pfizer is now promoting Relpax (eletriptan) for migraines. It's the seventh triptan to hit the market.

Relpax seems to be at least as effective as oral Imitrex (sumatriptan)...and might have a faster onset.

There are no direct comparisons with the other triptans.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote